PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...

In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 ...

A new study published in the Nature Scientific Reports showed that compared to kidney recipients who got preemptive transplants, individuals who experienced dialysis prior to transplantation are ...

Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy ...

However, left untreated, diabetic retinopathy will steadily get worse over time and start to affect your vision. Treatment can help prevent, delay, and reduce vision loss.

Diabetic retinopathy, a type of diabetic eye disease, is one of the leading causes of blindness in the United States. Despite this, almost 40% of people with diabetes don’t get an annual eye exam.

Statistical analysis showed a strong association between advanced diabetic retinopathy and an increased likelihood of heart ...

As India grapples with an escalating diabetes crisis, with 101 million1 diagnosed and 136 million with pre-diabetes, the ...

India, often labelled the diabetic capital of the world, faces an alarming crisis with over 77 million people diagnosed with ...